On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridayMar 31, 2017 3:27 pm

India Globalization Capital, Inc. (NYSE: IGC) From Mining to Marijuana

At first blush, India Globalization Capital (NYSE: IGC) would seem a curiosity clothed in an enigma. Just how does a NYSE company move from a successful mining orientation to a pioneer in the development of multiple cannabinoid-based pharmaceutical therapies to treat pain and disease? The enigma can be disrobed by looking at the tenacity and vision of its management. Ram Mukunda has served as Executive Chairman, CEO and President of India Global since inception in 2005. He holds distinguished mathematics and engineering degrees and worked in multiple Wall Street positions for more than 25 years, serving communications firms such as…

Continue Reading

ThursdayMar 30, 2017 12:37 pm

Singlepoint, Inc. (SING) Interview Reveals How the Cannabis Industry is Incorporating Technology

The legalization of cannabis across many states in the U.S. has opened doors to various innovators, leaving the tech world to rapidly adapt to this trending industry. There’s now a strong move by cannabis-oriented businesses to incorporate common technologies found in other industries, and such innovations are not just found in dispensaries. Improvements are being made on the technology surrounding the agricultural, marketing, production, and distribution channels in the marijuana market. Technology is also being used to solve challenging issues such as payment options. Singlepoint, Inc. (OTC: SING), a publicly traded holding company, offers payment solutions to the cannabis industry…

Continue Reading

ThursdayMar 30, 2017 8:30 am

Pain-Reducing Combination Therapies Proving Successful thanks to Innovative, Specialty Pharma Players

Combination therapies that use cannabis-based pain reduction methods without the negative side effects of opioids are looking to be a positive growth opportunity among specialty pharmaceuticals, particularly for postoperative and chronic pain relief. Leading specialty pharma companies such as India Globalization Capital, Inc. (NYSE: IGC) (IGC Profile), Cara Therapeutics, Inc. (NASDAQ: CARA), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), and INSYS Therapeutics, Inc. (NASDAQ: INSY) are tirelessly working to expand combination therapeutics product lines, while Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) developing an opioid alternative drug intended to reduce pain after surgery. To date, it is estimated that the annual national cost of…

Continue Reading

WednesdayMar 29, 2017 11:41 am

ChineseInvestors.com, Inc. (CIIX) Executes a First to Market Milestone

A population of over 1.2 billion people is one heck of a target market, especially when insulated by language. ChineseInvestors.com (OTCQB: CIIX) has leveraged this demographic to market a broad range of products, services and information specifically for the Chinese speaking population. The company provides real-time market commentary, analysis, and education-related services in the Chinese language and offers several types of subscription-based services. Headquartered in Los Angeles with offices in New York City and Shanghai, the company also offers consultation services to private companies seeking to go public, as well as advertising and public relations services. Seizing opportunity, this diverse…

Continue Reading

WednesdayMar 29, 2017 8:30 am

Marijuana Legalization Could Encourage Widespread Economic Benefits

There are a number of advantages to society and the public safety in regulating marijuana, but economic arguments also favor its legalization. The benefits include increased tax revenues, job creation, and reduced law enforcement costs. However, to legalize and regulate marijuana requires an ecosystem of support services like those provided by SinglePoint, Inc. (SING) (SING Profile), American Cannabis Company (AMMJ), Kush Bottles, Inc. (KSHB), mCig, Inc. (MCIG) and Terra Tech Corp. (TRTC). As a job-creating engine, the industry will be a super powerful diesel. Reporting on recently released data from New Frontier Data, Forbes(1) relates industry analyst projections that “by…

Continue Reading

TuesdayMar 28, 2017 12:13 pm

India Globalization Capital, Inc. (NYSE: IGC) Aims to Become a Leading Provider of Cannabis-Based Combination Therapies

India Globalization Capital, Inc. (NYSE MKT: IGC) has set a long-term goal for itself in the U.S. of becoming a leading provider of cannabis-based pharmaceutical and nutraceutical products. This is a transition away from its earlier short-term strategy, including the sale of electronics and development of a hotel site in Malaysia. To this end, the company has jettisoned its electronics business. IGC is now fully focused on building a portfolio of patents and starting clinical and pre-clinical trials for a series of pain-reducing and other cannabis-based therapies. These therapies are designed to treat neuropathic pain, seizures, Parkinson’s, anorexia/cachexia, Alzheimer’s, and…

Continue Reading

ThursdayMar 23, 2017 3:37 pm

ChineseInvestors.com, Inc. (CIIX) Set to Open California Retail Store, Launches XiBiDi Biotechnology in China

ChineseInvestors.com, Inc. (OTCQB: CIIX) is planning to open a retail store in San Gabriel, California, the same city in which the company is headquartered. The company also recently announced its new online cannabidiol (CBD) oil retail store would be operated by its newly-launched XiBiDi Biotechnology Co., Ltd subsidiary, which is headquartered in the Pudong Free-Trade Area of Shanghai, China. XiBiDi Biotechnology will focus on the online and offline sales of health products, including a range of hemp-derived food and beverages. In a news release, Warren Wang, founder and CEO of CIIX, said he was delighted with the registration and establishment…

Continue Reading

ThursdayMar 23, 2017 9:13 am

Singlepoint, Inc. (SING) CEO Greg Lambrecht Reveals High Points of Convectium Acquisition

Singlepoint, Inc. (OTC: SING), specializing in small- to mid-sized company acquisitions, recently began funding Convectium, an organization that sells equipment in the cannabis industry. There should be “more funding on the way,” according to Singlepoint CEO Greg Lambrecht, who discussed the acquisition in a recent episode of MoneyTV with Donald Baillargeon. Convectium sells machines that fill vials with oil, and it created a unique system for filling/packaging vape cartridges and disposable vape pens. These systems, and point of sale equipment, are sold at various trade shows, according to Lambrecht. In the phone interview, Lambrecht also revealed that Singlepoint is looking…

Continue Reading

WednesdayMar 22, 2017 8:30 am

Mixed Marijuana Messages from Trump Administration Make Diversification Imperative

Deciphering marijuana policy under the Trump Administration can be difficult, given differing statements by White House officials. Federal laws are at odds with a number of states that have legalized marijuana for medical and/or recreational use, and businesses like SinglePoint, Inc. (SING) (SING Profile), Corbus Pharmaceuticals Holdings, Inc. (CRBP), Medical Marijuana, Inc. (MJNA), Cannabis Science, Inc. (CBIS) and ChineseInvestors.com, Inc. (CIIX) (CIIX Profile) operate in a manner that hedges them against certain risks of federal prohibition. On the campaign trail, then-candidate Donald Trump said of medical marijuana on Fox News: “I'm in favor of it a hundred percent.” With regard…

Continue Reading

TuesdayMar 21, 2017 3:03 pm

India Globalization Capital, Inc. (NYSE: IGC) Pioneering New Phytocannabinoid Products

Although legal in 28 states for medicinal use, cannabis is still considered a dangerous substance in much of the country. However, many experts now believe that cannabis is a safe alternative to pharmaceuticals for relieving symptoms related to multiple illnesses. Scientific research shows that phytocannabinoids, cannabinoids that occur naturally in the cannabis plant, are effective at relieving convulsions, seizures, anxiety, nausea, and inflammation. From fighting glaucoma to controlling epileptic seizures and easing pain, scientific research has repeatedly shown the efficacy of medicinal marijuana. Due to government misclassification of cannabis as a Schedule 1 drug, there has been only marginal progress…

Continue Reading

Contact us: 303.498.7722